» Articles » PMID: 32390768

Urticaria: Recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology

Abstract

Background: Urticaria is a disorder affecting skin and mucosal tissues characterized by the occurrence of wheals, angioedema or both, the latter defining the urticaria-angioedema syndrome. It is estimated that 12-22% of the general population has suffered at least one subtype of urticaria during life, but only a small percentage (estimated at 7.6-16%) has acute urticaria, because it is usually self-limited and resolves spontaneously without requiring medical attention. This makes likely that its incidence is underestimated. The epidemiological data currently available on chronic urticaria in many cases are deeply discordant and not univocal, but a recent Italian study, based on the consultation of a national registry, reports a prevalence of chronic spontaneous urticaria of 0.02% to 0.4% and an incidence of 0.1-1.5 cases/1000 inhabitants/year.

Methods: We reviewed the recent international guidelines about urticaria and we described a methodologic approach based on classification, pathophysiology, impact on quality of life, diagnosis and prognosis, differential diagnosis and management of all the types of urticaria.

Conclusions: The aim of the present document from the Italian Society of Allergology, Asthma and Clinical Immunology (SIAAIC) and the Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA) is to provide updated information to all physicians involved in diagnosis and management of urticaria and angioedema.

Citing Articles

Chronic urticaria treatment challenges in children.

Ensina L, Brandao L, Melo A, Antila M, Ben-Shoshan M, Sole D Rev Paul Pediatr. 2025; 43():e2024107.

PMID: 39775610 PMC: 11654908. DOI: 10.1590/1984-0462/2025/43/2024107.


The Promising Role of Polyphenols in Skin Disorders.

Farhan M Molecules. 2024; 29(4).

PMID: 38398617 PMC: 10893284. DOI: 10.3390/molecules29040865.


Polyphenols from Mediterranean Plants: Biological Activities for Skin Photoprotection in Atopic Dermatitis, Psoriasis, and Chronic Urticaria.

Di Salvo E, Gangemi S, Genovese C, Cicero N, Casciaro M Plants (Basel). 2023; 12(20).

PMID: 37896042 PMC: 10609915. DOI: 10.3390/plants12203579.


Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.

Casale T, Gimenez-Arnau A, Bernstein J, Holden M, Zuberbier T, Maurer M Dermatol Ther (Heidelb). 2023; 13(11):2573-2588.

PMID: 37776480 PMC: 10613187. DOI: 10.1007/s13555-023-01040-9.


Urticaria: A Narrative Overview of Differential Diagnosis.

Schettini N, Corazza M, Schenetti C, Pacetti L, Borghi A Biomedicines. 2023; 11(4).

PMID: 37189714 PMC: 10136346. DOI: 10.3390/biomedicines11041096.


References
1.
Sabroe R, Francis D, Barr R, BLACK A, Greaves M . Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol. 1998; 102(4 Pt 1):651-8. DOI: 10.1016/s0091-6749(98)70283-0. View

2.
Oranje A . Management of urticaria and angioedema in children: new trends. G Ital Dermatol Venereol. 2010; 145(6):771-4. View

3.
Hiragun M, Hiragun T, Mihara S, Akita T, Tanaka J, Hide M . Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine. Allergy. 2012; 68(2):229-35. DOI: 10.1111/all.12078. View

4.
ODonnell B, Lawlor F, Simpson J, Morgan M, Greaves M . The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997; 136(2):197-201. View

5.
Platzer M, Grattan C, Poulsen L, Skov P . Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients. Allergy. 2005; 60(9):1152-6. DOI: 10.1111/j.1398-9995.2005.00841.x. View